Atlas Trials

Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery (PANDA IV)

Clinical trial NCT04444362 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT04444362
Sponsor
Nanjing Medical University
Status
ENROLLING_BY_INVITATION
Phase
Not Applicable
Study type
INTERVENTIONAL
Cardiovascular DiseaseCardiopulmonary Bypass
Start date
2025-01-01
Primary completion
2026-12-31
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.